3 Spam-Free Article(s) Found
Sort:
Date
Filter:
7d
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
BMY Bristol-Myers Squibb Company $61.3 $100.03B Uptrend
Article Searches
Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL http://www.zacks.com/stock/news/416134/roche-gets-fda-nod-for-venclexta-plus-gazyva-to-treat-cll?cid=CS-ZC-FT-416134 May 17, 2019 - Roche (RHHBY) gains an FDA nod for the sNDA of its leukemia drug, Venclexta, in combination with Gazyva for the treatment of previously untreated chronic lymphocytic leukemia.
Celgene Gets EC Nod for Label Expansion of Revlimid, Imnovid http://www.zacks.com/stock/news/416133/celgene-gets-ec-nod-for-label-expansion-of-revlimid-imnovid?cid=CS-ZC-FT-416133 May 17, 2019 - Celgene (CELG) obtains approval for the label expansion of oncology drugs Revlimid and Imnovid in Europe.
Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer http://www.zacks.com/stock/news/414385/pfizers-bavencio%2Binlyta-combo-gets-fda-nod-for-kidney-cancer?cid=CS-ZC-FT-414385 May 15, 2019 - Pfizer (PFE)/Merck KGaA's label expansion application for Bavencio as a treatment for advanced kidney cancer in combination with Inlyta gets approval in the United States.

Pages: 1

Page 1